✦ LIBER ✦

Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

✍ Scribed by Hess, K. R.; Anderson, K.; Symmans, W. F.; Valero, V.; Ibrahim, N.; Mejia, J. A.; Booser, D.; Theriault, R. L.; Buzdar, A. U.; Dempsey, P. J.

Book ID: 111924993
Publisher: American Society of Clinical Oncology
Year: 2006
Tongue: English
Weight: 362 KB
Volume: 24
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2006.05.6861

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemotherapy paclitaxel + do

Neoadjuvant chemotherapy paclitaxel + doxorubicin (PD) vs fluorouracil + doxorubicin + cyclophosphamide (FAC) in locally advanced breast cancer: Clinical and pathological response

✍ V.F. Semiglazov; A.A. Bojok; A.S. Arsumanov; O.A. Ivanova; V.G. Ivanov; V.V. Sem 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Neoadjuvant chemotherapy with cyclophosp

Neoadjuvant chemotherapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in 69 cases of locally advanced (stage IIIb) breast cancer

✍ Pankaj Gupta; Loveleen Bilani; Gaur K. Rath; Anoop Misra; Mahesh C. Mishra; Nuta 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 340 KB

Randomized trial of cyclophosphamide, ep

Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan

✍ Morihiko Kimura; Takeshi Tominaga; Yuichi Takatsuka; Masakazu Toi; Rikiya Abe; H 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 224 KB

Acute arterial thrombosis in a patient w

Acute arterial thrombosis in a patient with breast cancer after chemotherapy with 5-fluorouracil, doxorubicin, leucovorin, cyclophosphamide, and interleukin-3

✍ C. Theodossiou; G. Kroog; S. Ettinghausen; A. Tolcher; K. Cowan; J. O'Shaughness 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

Prospective randomized trial of 5-fluoro

Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control

✍ Jeffrey M. Albert; Aman U. Buzdar; Reina Guzman; Pamela K. Allen; Eric A. Strom; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 240 KB

Quality of life and toxicity in breast c

Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

✍ N. Hatam; N. Ahmadloo; A. Ahmad Kia Daliri; P. Bastani; M. Askarian 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 178 KB